70G logo

Cytophage Technologies DB:70G Stock Report

Last Price

€0.16

Market Cap

€9.1m

7D

-4.6%

1Y

n/a

Updated

12 Nov, 2024

Data

Company Financials

Cytophage Technologies Ltd.

DB:70G Stock Report

Market Cap: €9.1m

70G Stock Overview

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

70G fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Cytophage Technologies Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cytophage Technologies
Historical stock prices
Current Share PriceCA$0.16
52 Week HighCA$0.18
52 Week LowCA$0.14
Beta0.10
11 Month Changen/a
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-4.59%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

70GDE BiotechsDE Market
7D-4.6%-2.2%1.1%
1Yn/a-17.1%13.5%

Return vs Industry: Insufficient data to determine how 70G performed against the German Biotechs industry.

Return vs Market: Insufficient data to determine how 70G performed against the German Market.

Price Volatility

Is 70G's price volatile compared to industry and market?
70G volatility
70G Average Weekly Movementn/a
Biotechs Industry Average Movement5.8%
Market Average Movement4.7%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 70G's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 70G's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aSteven Theriaultcytophage.com

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Winnipeg, Canada.

Cytophage Technologies Ltd. Fundamentals Summary

How do Cytophage Technologies's earnings and revenue compare to its market cap?
70G fundamental statistics
Market cap€9.11m
Earnings (TTM)-€5.30m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
70G income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$7.85m
Earnings-CA$7.85m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.15
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did 70G perform over the long term?

See historical performance and comparison